Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124941944 | 12494194 | 4 | F | 20151208 | 20160728 | 20160623 | 20160802 | EXP | CN-ASTRAZENECA-2016SE49258 | ASTRAZENECA | 68.00 | YR | F | Y | 0.00000 | 20160802 | CN | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124941944 | 12494194 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | 2580 | UG | Y | U | 21773 | 5 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||
| 124941944 | 12494194 | 2 | SS | BYETTA | EXENATIDE | 1 | Subcutaneous | 2580 | UG | Y | U | 21773 | 10 | UG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | BID | |||
| 124941944 | 12494194 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 1 | DF | TABLET | BID | |||||||
| 124941944 | 12494194 | 4 | C | NOVONORM | REPAGLINIDE | 1 | Oral | 0 | 1 | DF | TABLET | QD | |||||||
| 124941944 | 12494194 | 5 | C | ACARBOSE. | ACARBOSE | 1 | Oral | 0 | 1 | DF | TABLET | TID | |||||||
| 124941944 | 12494194 | 6 | C | INSULIN | INSULIN NOS | 1 | 24 UNITS IN THE MORNING, 26 UNITS IN THE EVENING BEFORE RECEIVING BYETTA, AND DECREASED THE DOSE ... | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124941944 | 12494194 | 1 | Diabetes mellitus |
| 124941944 | 12494194 | 2 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124941944 | 12494194 | OT |
| 124941944 | 12494194 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124941944 | 12494194 | Blood glucose increased | |
| 124941944 | 12494194 | Coronary artery occlusion | |
| 124941944 | 12494194 | Decreased appetite | |
| 124941944 | 12494194 | Dizziness | |
| 124941944 | 12494194 | Fatigue | |
| 124941944 | 12494194 | Glycosylated haemoglobin increased | |
| 124941944 | 12494194 | Head discomfort | |
| 124941944 | 12494194 | Nausea | |
| 124941944 | 12494194 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124941944 | 12494194 | 1 | 20151208 | 20160108 | 0 | |
| 124941944 | 12494194 | 2 | 20160109 | 20160430 | 0 | |
| 124941944 | 12494194 | 4 | 2006 | 20151208 | 0 | |
| 124941944 | 12494194 | 5 | 2006 | 20151208 | 0 |